Top Markets
Coin of the day
Lumos Diagnostics Holdings Limited Lumos Diagnostics Holdings Limited

Lumos Diagnostics Holdings Limited

LDX
Rank in Stocks #23727
Lumos Diagnostics Holdings Limited develops, manufactures, and commercializes... Lumos Diagnostics Holdings Limited develops, manufactures, and commercializes point-of-care diagnostic products for diagnosis and management of infectious diseases in the United States. The company’s products include FebriDx, a point-of-care diagnostic test for detecting and differentiating viral and bacterial respiratory infections; and ViraDx, a three-in-one point-of-care test for influenza A, influenza B, and COVID-19. It also provides assay development and manufacturing services for point-of-care tests and proprietary digital reader platforms. Lumos Diagnostics Holdings Limited was incorporated in 2018 and is based in Carlsbad, California.
Share Price
$0.0740549
Last synced: 2026-08-21
Market Cap
$69.97M
Change (1 day)
0.00%
Change (1 year)
21.33%
Country
AU
Trade Lumos Diagnostics Holdings Limited (LDX)

Category

P/B ratio for Lumos Diagnostics Holdings Limited (LDX)
P/B ratio as of 2026 TTM: 0
According to Lumos Diagnostics Holdings Limited latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Lumos Diagnostics Holdings Limited from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors